Press Release

DSM announces Christophe Dardel as President of DSM Biomedical

Geleen, NL, 23 Jun 2010 17:15 CEST

DSM Biomedical, a global leader in biomedical materials science, announced today Mr. Christophe Dardel’s appointment as President effective May 21, 2010. Mr. Dardel succeeds Mr. Steve Hartig who served as the Company’s president since 2006.

In his new position, Mr. Dardel will oversee the strategic development and execution of DSM Biomedical’s global activities in Berkeley, CA, USA as well as Geleen, The Netherlands. The business will continue to focus on strengthening existing technology platforms and will explore opportunities to form strategic partnerships that complement its activities in the biomedical market.

Mr. Dardel has a long history of developing innovative business models and rapidly achieving growth goals. Most recently, Mr. Dardel served as President of DSM Dyneema, the inventor and manufacturer of Dyneema®, the world’s strongest fiber™, successfully expanding the company at an average growth rate of over 15% per year in the last eight years and building a strong global presence of the DSM Dyneema brand.

“I am honored to have been appointed President of DSM Biomedical,” said Mr. Dardel on his new role. “The Company has a strong track record and long history of supporting our customers in developing innovative solutions for the medical device market and I am excited by the opportunity to drive DSM Biomedical’s next phase of growth, building on the Company’s strengths in the biomedical industry and further improving our position as the market leader.“

Mr. Dardel holds a Masters of Science degree in Computer Science and Electronics from ESIEA in Paris and, prior to his roles with DSM, worked in team leadership and senior level management positions for Dyneon B.V., a subsidiary of 3M in The Netherlands, and E.I Dupont de Nemours for over a decade, based in France, Switzerland and The Netherlands.

Read more

  • Our products

    Our products

    DSM portfolio of innovative biomedical materials and process manufacturing technologies: Biomedical Polyethylenes, Biomedical polyurethanes, Collagen Technology, Device Development, and Extracellular Matrix (ECM) Technology. Learn more.

  • The markets we serve

    The markets we serve

    DSM Biomedical offers the broadest portfolio of biomedical materials and manufacturing across market applications, including orthopedics, ophthalmology, neurology, cardiology, diabetes, wound, and continence care.

This site uses cookies to store information on your computer.

Learn more